Nuclear targeting of β-catenin and p120ctn during thrombin-induced endothelial barrier dysfunction

Cardiovascular Research

Volumn 79, Issue 4, 2008, Pages 679-688

  Beckers, Cora M L ^a   García Vallejo, Juan J ^b   Van Hinsbergh, Victor W M ^a   Van Nieuw Amerongen, Geerten P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Molecular Cell Biology and Immunology ^*  (Netherlands)

Author keywords

Angiogenesis; Capillary permeability; Cell communication; Signal transduction; Vasoactive agents

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; PEPTIDES AND PROTEINS; PROTEIN P120CTN; RHO KINASE; THROMBIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CAPILLARY PERMEABILITY; CELL COMMUNICATION; CELL FUNCTION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; BETA CATENIN; CAPILLARY PERMEABILITY; CELL ADHESION MOLECULES; CELL MEMBRANE; CELLS, CULTURED; CYTOSOL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INTERCELLULAR JUNCTIONS; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; RHO-ASSOCIATED KINASES; RNA, MESSENGER; THROMBIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 52449106526     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn127     Document Type: Article

References (53)

1. Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 2007;100:158-173.
2. Dejana E. Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 2004;5:261-270.
3. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005;280:31906-31912.
4. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996;382:638-642.
5. Kim KI, Cho HJ, Hahn JY, Kim TY, Park KW, Koo BK et al. Beta-catenin overexpression augments angiogenesis and skeletal muscle regeneration through dual mechanism of vascular endothelial growth factor-mediated endothelial cell proliferation and progenitor cell mobilization. Arterioscler Thromb Vasc Biol 2006;26:91-98.
6. Korswagen HC, Herman MA, Clevers HC. Distinct beta-catenins mediate adhesion and signalling functions in C. elegans. Nature 2000;406:527-532.
7. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
8. Telo P, Breviario F, Huber P, Panzeri C, Dejana E. Identification of a novel cadherin (vascular endothelial cadherin-2) located at intercellular junctions in endothelial cells. J Biol Chem 1998;273:17565-17572.
9. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G et al. A novel endothelial-specific membrane-protein is a marker of cell-cell contacts. J Cell Biol 1992;118:1511-1522.
10. Aberle H, Schwartz H, Kemler R. Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem 1996;61:514-523.
11. Hirano S, Nose A, Hatta K, Kawakami A, Takeichi M. Calcium-dependent cell-cell adhesion molecules (cadherins): subclass specificities and possible involvement of actin bundles. J Cell Biol 1987;105:2501-2510.
12. Reynolds AB, Herbert L, Cleveland JL, Berg ST, Gaut JR. p120, a novel substrate of protein tyrosine kinase receptors and of p60v-src, is related to cadherin-binding factors beta-catenin, plakoglobin and armadillo. Oncogene 1992;7:2439-2445.
13. Molenaar M, van de Wetering M, Oosterwegel M, Peterson Maduro J, Godsave S, Korinek V et al. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 1996;86:391-399.
14. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997;16:3797- 3804.
15. Eberhart CG, Tihan T, Burger PC. Nuclear localization and mutation of beta-catenin in medulloblastomas. J Neuropathol Exp Neurol 2000;59:333-337.
16. Blankesteijn WM, van Gijn ME, Essers-Janssen YP, Daemen MJ, Smits JF. Beta-catenin, an inducer of uncontrolled cell proliferation and migration in malignancies, is localized in the cytoplasm of vascular endothelium during neovascularization after myocardial infarction. Am J Pathol 2000;157:877-883.
17. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H. Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 2002;277:17901-17905.
18. Eto M, Kouroedov A, Cosentino F, Luscher TF. Glycogen synthase kinase-3 mediates endothelial cell activation by tumor necrosis factor-alpha. Circulation 2005;112:1316-1322.
19. Couffinhal T, Dufourcq P, Duplaa C. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation? Circ Res 2006;99:1287-1289.
20. Gottardi CJ, Gumbiner BM. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 2004;167:339-349.
21. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
22. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
23. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-5527.
24. Haertel-Wiesmann M, Liang Y, Fantl WJ, Williams LT. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 2000;275:32046-32051.
25. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AM. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res 1999;59:1572-1577.
26. Masckauchan TN, Shawber CJ, Funahashi Y, Li CM, Kitajewski J. Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis 2005;8:43-51.
27. Kim TH, Xiong H, Zhang Z, Ren B. Beta-catenin activates the growth factor endothelin-1 in colon cancer cells. Oncogene 2005;24:597-604.
28. Park JI, Ji H, Jun S, Gu D, Hikasa H, Li L et al. Frodo links Dishevelled to the p120-catenin/Kaiso pathway: distinct catenin subfamilies promote Wnt signals. Dev Cell 2006;11:683-695.
29. Soubry A, van Hengel J, Parthoens E, Colpaert C, Van Marck E, Waltregny D et al. Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment. Cancer Res 2005;65:2224-2233.
30. Goodwin AM, D'Amore PA. Wnt signaling in the vasculature. Angiogenesis 2002;5:1-9.
31. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-257.
32. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VWM. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 2003;23:211-217.
33. Cavallaro U, Liebner S, Dejana E. Endothelial cadherins and tumor angiogenesis. Exp Cell Res 2006;312:659-667.
34. van Nieuw Amerongen GP, Draijer R, Vermeer MA, van Hinsbergh VWM. Transient and prolonged increase in endothelial permeability induced by histamine and thrombin: role of protein kinases, calcium, and RhoA. Circ Res 1998;83:1115-1123.
35. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
36. Kouklis P, Konstantoulaki M, Vogel S, Broman M, Malik AB. Cdc42 regulates the restoration of endothelial barrier function. Circ Res 2004;94:159-166.
37. Nilsson I, Shibuya M, Wennstrom S. Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res 2004;299:476-485.
38. van der Sar AM, Musters RJP, van Eeden FJM, Appelmelk BJ, van den Broucke-Grauls CMJ, Bitter W. Zebrafish embryos as a model host for the real time analysis of Salmonella typhimurium infections. Cell Microbiol 2003;5:601-611.
39. García-Vallejo JJ, van het Hof B, Robben J, van Wijk JA, van Die I, Joziasse DH et al. Approach for defining endogenous reference genes in gene expression experiments. Anal Biochem 2004;329:293-299.
40. Liebner S, Cavallaro U, Dejana E. The multiple languages of endothelial cell-to-cell communication. Arterioscler Thromb Vasc Biol 2006;26:1431-1438.
41. Konstantoulaki M, Kouklis P, Malik AB. Protein kinase C modifications of VE-cadherin, p120, and beta-catenin contribute to endothelial barrier dysregulation induced by thrombin. Am J Physiol Lung Cell Mol Physiol 2003;285:L434-L442.
42. Birukova AA, Malyukova I, Poroyko V, Birukov KG. Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2007;293:L199-L211.
43. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006;8:1223-1234.
44. Xiao K, Garner J, Summers S, Buckley KM, Dejana E, Faundez V et al. p120 catenin regulates clathrin-dependent endocytosis of VE-cadherin. J Invest Dermatol 2005;124:A30.
45. Piedra J, Martinez D, Castano J, Miravet S, Dunach M, de Herreros AG. Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 2001;276:20436-20443.
46. van Nieuw Amerongen GP, van Delft S, Vermeer MA, van Hinsbergh VWM. Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res 2000;87:335-340.
47. Habas R, Kato Y, He X. Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell 2001;107:843-854.
48. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002;108:837-847.
49. Thors B, Halldorsson H, Clarke GD, Thorgeirsson G. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C. Atherosclerosis 2003;168:245-253.
50. Skurk C, Maatz H, Rocnik E, Bialik A, Force T, Walsh K. Glycogen-synthase kinase3 beta/beta-catenin axis promotes angiogenesis through activation of vascular endothelial growth factor signaling in endothelial cells. Circ Res 2005;96:308-318.
51. Kondapalli J, Flozak AS, Albuquerque ML. Laminar shear stress differentially modulates gene expression of p120 catenin, Kaiso transcription factor, and vascular endothelial cadherin in human coronary artery endothelial cells. J Biol Chem 2004;279:11417-11424.
52. Spring CM, Kelly KF, O'Kelly I, Graham M, Crawford HC, Daniel JM. The catenin p120ctn inhibits Kaiso-mediated transcriptional repression of the beta-catenin/TCF target gene matrilysin. Exp Cell Res 2005;305:253-265.
53. Ichikawa Y, Ishikawa T, Momiyama N, Kamiyama M, Sakurada H, Matsuyama R et al. Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol Rep 2006;15:311-315.